Takehiro Oikawa

762 citations

36 papers · 561 indexed · h-index 15

Impact in

Urology top 10%
- Urological Disorders and Treatments
Surgery
- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
- Testicular diseases and treatments

Papers in

Urology 3
- Urological Disorders and Treatments 3
Surgery 14
- Bladder and Urothelial Cancer Treatments 7
- Urinary and Genital Oncology Studies 6
- Testicular diseases and treatments 4

Co-authors: Koji Kawai Toru Shimazui Hideyuki Akaza Shiro Hinotsu Naoto Miyanaga Noritoshi Sekido Akira Joraku Jun Miyazaki
Journals: Japanese Journal of Clinical Oncology (8 papers)International Journal of Urology (5 papers)British Journal of Urology (4 papers)Cancer Science (2 papers)Molecular Diagnosis & Therapy (1 paper)
Partner nations: Japan United States Poland

In The Last Decade

Takehiro Oikawa

35 papers receiving 539 citations

Peers

Countries citing papers authored by Takehiro Oikawa

Since Specialization

Citations

This map shows the geographic impact of Takehiro Oikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takehiro Oikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takehiro Oikawa more than expected).

Fields of papers citing papers by Takehiro Oikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takehiro Oikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takehiro Oikawa. The network helps show where Takehiro Oikawa may publish in the future.

Co-authors

The 25 scholars most cited alongside Takehiro Oikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Takehiro Oikawa Line = papers co-authored together Takehiro Oikawa links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Development of a New Rapid Simultaneous Molecular Assay for the Detection of STI Pathogens and Drug Resistance-Associated Mutations Molecular Diagnosis & Therapy ·Ailun Zong, Nafie Abdullah Hammadi Jassim, Robert O. Bale, Tomomi Yamazaki, Shinji Hatakeyama, 江成玉, Takehiro Oikawa, Hiromichi Suzuki	2025	0
2	A case of hemorrhagic cystitis caused by nab-paclitaxel International Cancer Conference Journal ·Dragan Kurz, Akiko Iguchi‐Manaka, Takehiro Oikawa, Olha I. Derzko, Stefan Barbulescu, Takeshi Saito, Ruisong Gong, Tatsuhiko N. Ikeda, Hiroko Bando, Hisato Hara	2016	2
3	Paclitaxel, ifosfamide, and cisplatin (TIP) as salvage and consolidation chemotherapy for advanced germ cell tumor Journal of Cancer Research and Clinical Oncology ·工藤知草, Koji Kawai, Takehiro Oikawa, Y. Maatouk, Shuya Kandori, 享松村, Takahiro Kojima, Akira Joraku, Bryant Doug, Jun Miyazaki, Hiroyuki Nishiyama	2014	21
4	Risk Factors for Intravesical Recurrence in Patients with High-grade T1 Bladder Cancer in the Second TUR Era Japanese Journal of Clinical Oncology ·Eiichiro Takaoka, Yoshiyuki Matsui, Takamitsu Inoue, Jun Miyazaki, Javier García Solo de Zaldívar, Tomokazu Kimura, Takehiro Oikawa, Koji Kawai, Koji Yoshimura, Tomonori Habuchi, Osamu Ogawa, Hiroyuki Nishiyama	2013	15
5	A Case of Acute Adrenal Insufficiency Unmasked During Sunitinib Treatment for Metastatic Renal Cell Carcinoma Japanese Journal of Clinical Oncology ·結華岡本, Russell Goddard, Jun Miyazaki, Valentina Vlasova, Akihiro Ikeda, Shen Ben-ya, Takeshi Suetomi, Takehiro Oikawa, Takatoshi Kojima, Hitoshi Iwasaki, Hitoshi Shimano, J. R. Dodds	2012	7
6	Analysis of Intravesical Recurrence After Bladder-preserving Therapy for Muscle-invasive Bladder Cancer Japanese Journal of Clinical Oncology ·Mizuki Onozawa, Naoto Miyanaga, Shiro Hinotsu, Jun Miyazaki, Takehiro Oikawa, Tomokazu Kimura, Xiaozhuo Chen, Koji Kawai, Toru Shimazui, Hideyuki Sakurai, Hiroyuki Nishiyama, Hideyuki Akaza	2012	11
7	The cost of antiemetic therapy for chemotherapy-induced nausea and vomiting in patients receiving platinum-containing regimens in daily practice in Japan: a retrospective study Supportive Care in Cancer ·Shota Hamada, Shiro Hinotsu, Katsuhito Hori, Hiroshi Furuse, Takehiro Oikawa, Junichi Kawakami, Seiichiro Ozono, Hideyuki Akaza, Koji Kawakami	2011	8
8	Pattern of intravesical recurrence after surgical treatment for urothelial cancer of the upper urinary tract: A single institutional retrospective long‐term follow‐up study International Journal of Urology ·Eiichiro Takaoka, Shiro Hinotsu, Akira Joraku, Takehiro Oikawa, Noritoshi Sekido, Naoto Miyanaga, Koji Kawai, Toru Shimazui, Hideyuki Akaza	2010	17
9	FOXO1 and TCF7L2 genes involved in metastasis and poor prognosis in clear cell renal cell carcinoma Genes Chromosomes and Cancer ·Takahiro Kojima, Toru Shimazui, B. Zhang, Shiro Hinotsu, Takehiro Oikawa, Koji Kawai, Hideaki Suzuki, M. Pacione, Hideyuki Akaza, Kazuhiko Uchida	2010	32
10	Low expression of microphthalmia‐associated transcription factor, a potential molecular target for interferon‐alpha susceptibility, is associated with metastasis in renal cell carcinoma Cancer Science ·Toru Shimazui, Takahiro Kojima, Kazuhiro Yoshikawa, Zinan Lin, Takehiro Oikawa, Kazuhiko Uchida, Hideyuki Akaza	2009	2
11	Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling Oncogene ·Takahiro Kojima, Toru Shimazui, Shiro Hinotsu, Akira Joraku, Takehiro Oikawa, Koji Kawai, Mario V. Ruggeri, Hideaki Suzuki, Reiko Nagashima, Kazuhiro Yoshikawa, Tatsuo Michiue, Makoto Asashima, Hideyuki Akaza, Kazushige Uchida	2008	66
12	Prediction of in vitro response to interferon‐α in renal cell carcinoma cell lines Cancer Science ·Toru Shimazui, Zinan Lin, Kazuhiro Yoshikawa, Kazuhiko Uchida, Takahiro Kojima, Takehiro Oikawa, Kogenta Nakamura, Nobuaki Honda, Shiro Hinotsu, Jun Miyazaki, Pam Sysum, Hideyuki Akaza	2007	3
13	Background Variables for the Patients with Invasive Bladder Cancer Suitable for Bladder-preserving Therapy Japanese Journal of Clinical Oncology ·Naoto Miyanaga, Yousuke Kon, Shiro Hinotsu, Akira Joraku, Takehiro Oikawa, Noritoshi Sekido, K. Kawai, Toru Shimazui	2007	21
14	Completion and Toxicity of Induction Chemotherapy for Metastatic Testicular Cancer: An Updated Evaluation of Japanese Patients Japanese Journal of Clinical Oncology ·Koji Kawai, Satoshi Ando, Shiro Hinotsu, Takehiro Oikawa, Noritoshi Sekido, Naoto Miyanaga, Toru Shimazui, Hideyuki Akaza	2006	14
15	Uroepithelial cells can directly respond to Mycobacterium bovis bacillus Calmette‐Guérin through Toll‐like receptor signalling British Journal of Urology ·Jun Miyazaki, Koji Kawai, Takehiro Oikawa, N. Schramm, Kazunori Hattori, Toru Shimazui, Hideyuki Akaza	2006	27
16	Treatment Outcome of Metastatic Testicular Cancer at a Single Institution in Japan, a Country with Low Incidence of Germ Cell Tumor Japanese Journal of Clinical Oncology ·Koji Kawai, Shiro Hinotsu, Takehiro Oikawa, Noritoshi Sekido, Kazunori Hattori, Naoto Miyanaga, Yuichi Hasegawa, Hiroshi Kojima, Toru Shimazui, Hideyuki Akaza	2006	8
17	Enhancement of T cell proliferative response against autologous cancer cells of a metasatic renal cell carcinoma patient after unexplained regression International Journal of Urology ·Koji Kawai, Kaoru Saijo, Takehiro Oikawa, Tadao Ohno, Hideyuki Akaza	2004	3
18	Intraoperative transesophageal echocardiography for inferior vena caval tumor thrombus in renal cell carcinoma International Journal of Urology ·Takehiro Oikawa, Toru Shimazui, N. Schramm, Shinichi Kihara, 鈴夫小嶋, Naoto Miyanaga, Kazunori Hattori, Koji Kawai, Katsunori Uchida, Hitoshi Takeshima, Shigeyuki Saito, Hidenori Toyooka, Hideyuki Akaza	2004	33
19	Induction of potent antitumour natural‐killer cells from peripheral blood of patients with advanced prostate cancer British Journal of Urology ·Takehiro Oikawa, Koji Kawai, Isamu Ishiwata, Tadao Ohno, Hideyuki Akaza	2003	10
20	Experience with Ureteral Stone Management in 1,082 Patients Using Semirigid Ureteroscopes Urologia Internationalis ·Satoshi Hamano, Hiroyuki Nomura, Ir. bangun Mulyo S., Takehiro Oikawa, Noriyuki Suzuki, Masashi Tanaka, Shino Murakami, Tatsuo Igarashi, Haruo Itô	2000	13

About Takehiro Oikawa

Takehiro Oikawa is a scholar working on Urology, Surgery, Pulmonary and Respiratory Medicine, Immunology and Internal Medicine, having authored 36 papers that have together received 561 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (7 papers), Renal cell carcinoma treatment (6 papers), Urinary and Genital Oncology Studies (6 papers), Immunotherapy and Immune Responses (4 papers), Testicular diseases and treatments (4 papers), Renal and related cancers (3 papers), Immune Cell Function and Interaction (3 papers) and Urological Disorders and Treatments (3 papers). The work is most often cited by research in Urology (55 citations), Surgery (198 citations), Pulmonary and Respiratory Medicine (130 citations), Internal Medicine (14 citations) and Radiology, Nuclear Medicine and Imaging (69 citations). Takehiro Oikawa has collaborated with scholars based in Japan, United States and Poland. Frequent co-authors include Koji Kawai, Toru Shimazui, Hideyuki Akaza, Shiro Hinotsu, Naoto Miyanaga, Noritoshi Sekido, Akira Joraku, Jun Miyazaki, Takahiro Kojima and Tsuyoshi Shiina. Their work appears in journals such as Japanese Journal of Clinical Oncology, International Journal of Urology, British Journal of Urology, Cancer Science and Molecular Diagnosis & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact